Following the CDC guidance of a 28-day refrigerated-use window, that works out to three 80 mg vials at the low 1.6 mg dose, three vials at the standard 3.2 mg dose, or four vials at the elevated 4.8 mg dose
However, 10 PWS patients showed no significant changes in BMI, weight z -score, and ghrelin when the effectiveness was measured after 6 months of exenatide use, even though improved HbA1c level and decreasing appetite scores were noted [12]
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist approved for type 2 diabetes management and chronic weight management, requires specific storage conditions to maintain its stability and therapeutic efficacy
This treatment is reserved for individuals requiring the absolute maximum in antioxidant support, whether for chronic health conditions, intensive anti-aging protocols, or comprehensive wellness optimization